|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-6-26
|
|
pubmed:abstractText |
Identification of the prognosis of patients with gliomas is important for selecting and evaluating the effectiveness of treatment. The aim of this study was to evaluate the Ki-67 labeling index (LI) using the newly generated MIB-1 monoclonal antibody (MoAb) as a prognostic indicator for patients with astrocytomas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
373-80
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8625247-Adolescent,
pubmed-meshheading:8625247-Adult,
pubmed-meshheading:8625247-Aged,
pubmed-meshheading:8625247-Antibodies, Monoclonal,
pubmed-meshheading:8625247-Astrocytoma,
pubmed-meshheading:8625247-Brain Neoplasms,
pubmed-meshheading:8625247-Cell Division,
pubmed-meshheading:8625247-Child,
pubmed-meshheading:8625247-Female,
pubmed-meshheading:8625247-Glioblastoma,
pubmed-meshheading:8625247-Humans,
pubmed-meshheading:8625247-Immunoenzyme Techniques,
pubmed-meshheading:8625247-Ki-67 Antigen,
pubmed-meshheading:8625247-Male,
pubmed-meshheading:8625247-Middle Aged,
pubmed-meshheading:8625247-Neoplasm Proteins,
pubmed-meshheading:8625247-Nuclear Proteins,
pubmed-meshheading:8625247-Prognosis
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
|
|
pubmed:affiliation |
Department of Neurosurgery, School of Medicine, Tokyo Medical and Dental University, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
